ArticleJournal of diabetes investigation2019

Case of fulminant type 1 diabetes induced by the anti-programmed death-ligand 1 antibody, avelumab.

Yui Shibayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.